Darbepoetin alpha

This page shows anti-doping rule violation data we have registered for Darbepoetin alpha.

Number of cases in Darbepoetin alpha Last 10 Years

Darbepoetin alpha

Darbepoetin alpha ranks #74 globally among prohibited substances, with 38 registered cases (0.3% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,670 verified cases. India leads with 17 cases, while Track and field is the most affected sport (23 cases).

Cases of Darbepoetin alpha by Sport
Track and field
23
Cycling
11
Cross-country skiing
4
Top Sport: Track and field

23

Track and field cases

0%

Of all violations

38

Total Darbepoetin alpha cases
Track and field's share of Darbepoetin alpha violations 0%
23 of 38

Track and field has the most recorded cases of Darbepoetin alpha violations globally, with 23 registered cases — 0% of all 38 verified cases.

Cases of Darbepoetin alpha by Country
India
17
Italy
8
Russia
4
France
3
Spain
1
Top Country: India

17

India cases

44.7%

Of all violations

38

Total Darbepoetin alpha cases
India's share of Darbepoetin alpha violations 44.7%
17 of 38

India dominates Darbepoetin alpha violations globally, with 17 registered cases — 44.7% of all 38 verified cases.

Global Substance Ranking

Darbepoetin alpha ranks #74 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,359
#2 Methandienone
833
#3 Norandrosterone
778
#4 Testosterone
758
···
#74 Darbepoetin alpha
38
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 76.3%
29 cases
Female 23.7%
9 cases
Analysis: 's gender distribution (76.3% male, 23.7% female) aligns closely with the global average. Global average: 80.2% male, 19.8% female
Average Suspension Length
36.4
months
Darbepoetin alpha
30.1
months
Global average

The average suspension for Darbepoetin alpha violations is 36.4 months, longer than the global average of 30.1 months.

Darbepoetin (Aranesp) is a substance analogue and mimetic of recombinant EPO (r-EPO).

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,670 verified anti-doping rule violations across all sports and all countries, and is updated regularly.